Temat: obstructive diseases - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: An application supporting the educational process of the respiratory system obstructive diseases detection
Aplikacja wspomagająca procesy edukacyjne w zakresie wykrywania chorób obturacyjnych układu oddechowego
Autorzy:: Jaworski, J.
Tojza, P. M.
Powiązania:: https://bibliotekanauki.pl/articles/276600.pdf
Data publikacji:: 2013
Wydawca:: Sieć Badawcza Łukasiewicz - Przemysłowy Instytut Automatyki i Pomiarów
Tematy:: aplikacja komputerowa
choroby obturacyjne
płuca
computer application
obstructive diseases
lungs
Opis:: The paper presents a description of functioning of a platform supporting the detection of obstructive diseases in the respiratory system education process. A 16-parameter model of the respiratory system simulated in the MATLAB/Simulink environment was set in the role of the tested patient. It has been linked to the control layer, developed in the LabVIEW environment, using the SIT library (Simulation Interface Toolkit). This layer is responsible for the modification of the model's parameters and the generation of the results of the respiratory impedance measurements using forced oscillation method. The application is a solution that provides a lot of flexibility in the education of students studying courses related to biomedical engineering and health sciences, and can easily be implemented to work as a problem-oriented e-learning solution.
W publikacji zaprezentowano działanie platformy wspomagającej edukację w zakresie wykrywania chorób obturacyjnych układu oddechowego. Rolę badanego pacjenta pełni 16-elementowy model układu oddechowego, symulowany w środowisku MATLAB/Simulink. Został on połączony z warstwą sterowania, wykonaną w środowisku LabVIEW, przy pomocy biblioteki SIT (Simulation Interface Toolkit). Warstwa ta odpowiada za modyfikację parametrów modelu oraz generowanie wyników pomiaru impedancji układu oddechowego za pomocą oscylacji wymuszonych. Wykonana aplikacja jest rozwiązaniem zapewniającym dużą elastyczność w kształceniu studentów związanych inżynierią biomedyczną i naukami o zdrowiu i bardzo łatwo może być wdrożona do pracy jako rozwiązanie e-learningowe, zorientowane problemowo.
Źródło:: Pomiary Automatyka Robotyka; 2013, 17, 2; 230-233
1427-9126
Pojawia się w:: Pomiary Automatyka Robotyka
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 2.

Tytuł:: Exhaled nitric oxide in smokers and former smokers with chronic obstructive pulmonary disease
Autorzy:: Galiniak, S.
Aebisher, D.
Rachel, M.
Powiązania:: https://bibliotekanauki.pl/articles/2087917.pdf
Data publikacji:: 2020
Wydawca:: Uniwersytet Opolski. Instytut Nauk o Zdrowiu
Tematy:: nitric oxide
smoking
respiratory diseases
chronic obstructive pulmonary disease
Opis:: Background: Measurement of fractional exhaled nitric oxide (FeNO) is a useful technique for detection of eosinophilic airway inflammation and assessment of efficiency of corticosteroid treatment in patents with respiratory disease. Generally studies agree that measurement of FeNO is a useful non-invasive biomarker in patients with chronic obstructive pulmonary disease (COPD), however, there are reports that do not confirm such a relationship between FeNO and COPD. Aim of the study: The main objective of this study was to investigate FeNO levels in Polish patients with COPD compared to healthy controls. As a secondary objective, we assessed the influence of smoking on FeNO levels in healthy patients, and patients with COPD. Material and methods: FeNO concentration was measured using an electrochemical analyzer in healthy nonsmokers (n=21), healthy smokers (n=25), and former smokers with COPD (n=30) and smokers with COPD (n=38). General characteristics, hematological variables and serum biochemical parameters were also obtained and analyzed using the Kruskal-Wallis test. Results: FeNO measurement revealed significantly reduced NO levels in healthy smokers compared to healthy non-smokers, former smokers with COPD and smokers with COPD (median [range]: 14 [6–17] vs. 21 [15–29], 25 [15–53], and 19 [11–32] ppb, respectively, p<0.001). Moreover, we found increased FeNO levels in ex-smokers with COPD compared with smokers with COPD (p<0.05). No associations between FeNO and other analyzed parameters were found. Conclusions: Levels of FeNO, measured by with an electrochemical analyzer, were elevated among patients with COPD compared to healthy non-smoking controls. Moreover, our study confirms that smoking results in a reduction in FeNO concentration in both healthy patients and patients with COPD.
Źródło:: Medical Science Pulse; 2020, 14, 2; 36-43
2544-1558
2544-1620
Pojawia się w:: Medical Science Pulse
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 3.

Tytuł:: Nanomedicine - a boon for respiratory disease management
Autorzy:: Balasubramanian, D.
Lavanya, S.J.
Girigoswami, A.
Girigoswami, K.
Powiązania:: https://bibliotekanauki.pl/articles/24200620.pdf
Data publikacji:: 2023
Wydawca:: Stowarzyszenie Komputerowej Nauki o Materiałach i Inżynierii Powierzchni w Gliwicach
Tematy:: nanomedicine
asthma
chronic obstructive pulmonary disease
cystic fibrosis
respiratory diseases
nanomedycyna
astma
przewlekła obturacyjna choroba płuc
mukowiscydoza
choroby układu oddechowego
Opis:: Purpose: Respiratory diseases affect the lungs and other parts of the respiratory system. The respiratory disease affects hundreds of millions of humans, and premature death is observed in nearly four million people yearly. The major cause of the increase in this disease is the increased level of air pollution and higher tobacco usage in public places. Design/methodology/approach: We have used the search engines PubMed and Google Scholar for the keywords Respiratory diseases, Nanomaterials, diagnosis, Nanomedicine, and Target drug delivery; recent and relevant articles are selected for reviewing this paper. Findings: Nanomedicine is a recent field of research that deals with monitoring, repairing, theragnosis, and development of human biological systems at the sub-atomic level, where we utilize engineered nanodevices and nanostructures. The conventional therapeutic strategies designed for respiratory diseases have limited solubility and bioavailability. Moreover, the robust effect of the drugs led to adverse side effects due to their high dose requirement. The local delivery of therapeutic Nanoparticles (NPs) or drug-loaded nano vehicles to the lung is a safe technique for managing various respiratory tract-related diseases like chronic obstructive pulmonary diseases, cystic fibrosis, lung cancer, tuberculosis, asthma, and infection. To overcome the difficulties of conventional treatment with antibiotics and anti-inflammatory drugs, nano-enabled drug delivery, nanoformulations of drugs as well as drug nanoencapsulation have been used recently. In this mini-review, we will discuss the importance and application of nanomedicine for diagnosis, treatment and clinical research involved in the different types of respiratory diseases. Practical implications: Nanomedicine provides an alternative delivery of drugs with the help of various nanocarriers, which enhances controlled drug delivery at the pulmonary region and can be used for treating and diagnosing respiratory diseases in vivo and in vitro studies. Further experiments followed by clinical examination are warranted to prove the potential application of nanomedicine in treating respiratory disease. Originality/value: This mini-review will help the readers and budding scientists apply new methods for developing highly efficient drugs with low side effects and improved targeted sites of action.
Źródło:: Archives of Materials Science and Engineering; 2023, 119, 2; 71--85
1897-2764
Pojawia się w:: Archives of Materials Science and Engineering
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Informacja

Wyszukujesz frazę "obstructive diseases" wg kryterium: Temat

Źródło danych

Dostawca treści

Kolekcja

Rok wydania

Wydawca

Temat

Autor

Typ dokumentu

Język